Dogwood Therapeutics, Inc.
A biotech company developing novel therapeutics for pain and neuropathy.
DWTX | US
Overview
Corporate Details
- ISIN(s):
- US92829J2033 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 44 MILTON AVENUE, 30009 ALPHARETTA
- Website:
- https://dwtx.com/
Description
Dogwood Therapeutics, Inc. is a development-stage biotechnology company that focuses on advancing novel therapeutics for pain and neuropathy. The company's pipeline is centered on developing treatments for conditions such as moderate-to-severe chemotherapy-induced neuropathic pain, cancer pain, and other pain- and fatigue-related disorders. A key area of its research involves the development of novel sodium channel blockers, including its candidate Halneuron.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
|
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB
Full Filing History RestrictedAccess to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset. |
|||||
Automate Your Workflow. Get a real-time feed of all Dogwood Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Dogwood Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Dogwood Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
